"Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action". European Journal of Pharmacology. 216 (1): 67-71. May 1992. doi:10.1016/0014-2999(92)90210-u. PMID1388121.
"Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo". Pharmacology & Toxicology. 66 Suppl 1: 29-33. 1990. doi:10.1111/j.1600-0773.1990.tb01603.x. PMID2304893.
"Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action". European Journal of Pharmacology. 216 (1): 67-71. May 1992. doi:10.1016/0014-2999(92)90210-u. PMID1388121.
"The effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivo". The Journal of Pharmacology and Experimental Therapeutics. 263 (1): 180-5. October 1992. PMID1403783.
"Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo". Pharmacology & Toxicology. 66 Suppl 1: 29-33. 1990. doi:10.1111/j.1600-0773.1990.tb01603.x. PMID2304893.
"[Practical experiences in the therapy of postweaning edema disease in piglets]". Berliner und Munchener Tierarztliche Wochenschrift. 109 (10): 385-7. October 1996. PMID8999770.